James W. Checco

Prof. James W. Checco

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2015 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JCJames W. Checco
James W. Checco
Erinna LeeErinna Lee
Erinna Lee
MEMarco Evangelista
Marco Evangelista
NSNerida J. Sleebs
Nerida J. Sleebs
KRKelly Rogers
Kelly Rogers
Walter FairlieWalter Fairlie
Walter Fairlie

30 March 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JCJames W. Checco
James W. Checco
DKDale F. Kreitler
Dale F. Kreitler
NTNicole C. Thomas
Nicole C. Thomas
DBDavid G. Belair
David G. Belair
NRNicholas J. Rettko
Nicholas J. Rettko
SGSamuel H. Gellman
Samuel H. Gellman
Peptide-based agents derived from well-defined scaffolds offer an alternative to antibodies for selective and high-affinity recognition of large and topologically complex protein surfaces. Here, we describe a strategy for designing oligomers containing both α- and β-amino acid residues (“α/β-peptides”) that mimic several peptides derived from the three-helix bundle “Z-domain” scaffold. We show that α/β-peptides derived from a Z-domain peptide targeting vascular endothelial growth factor (VEGF) can structurally and functionally mimic the binding surface of the parent peptide while exhibiting significantly decreased susceptibility to proteolysis. The tightest VEGF-binding α/β-peptide inhibits the VEGF165-induced proliferation of human umbilical vein endothelial cells. We demonstrate the versatility of this strategy by showing how principles underlying VEGF signaling inhibitors can be rapidly extended to produce Z-domain–mimetic α/β-peptides that bind to two other protein partners, IgG and tumor necrosis factor-α. Because well-established selection techniques can identify high-affinity Z-domain derivatives from large DNA-encoded libraries, our findings should enable the design of biostable α/β-peptides that bind tightly and specifically to diverse targets of biomedical interest. Such reagents would be useful for diagnostic and therapeutic applications.

1 May 2012 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
HHHolly S. Haase
Holly S. Haase
KPKimberly J. Peterson-Kaufman
Kimberly J. Peterson-Kaufman
SLSheeny K. Lan Levengood
Sheeny K. Lan Levengood
JCJames W. Checco
James W. Checco
WMWilliam L. Murphy
William L. Murphy
SGSamuel H. Gellman
Samuel H. Gellman

1 August 2016 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
JCJames W. Checco
James W. Checco
SGSamuel H Gellman
Samuel H Gellman

8 August 2013 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
BSBrian J. Smith
Brian J. Smith
Erinna LeeErinna Lee
Erinna Lee
JCJames W. Checco
James W. Checco
MEMarco Evangelista
Marco Evangelista
SGSamuel H. Gellman
Samuel H. Gellman
Walter FairlieWalter Fairlie
Walter Fairlie

1 October 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JCJames W. Checco
James W. Checco
GZGuo Zhang
Guo Zhang
WYWang-Ding Yuan
Wang-Ding Yuan
ZLZi-Wei Le
Zi-Wei Le
JJJian Jing
Jian Jing
JSJonathan Sweedler
Jonathan Sweedler
L- to D-residue isomerization is a post-translational modification (PTM) present in neuropeptides, peptide hormones, and peptide toxins from several animals. In most cases, the D-residue is critical for the biological function of the resulting D-amino acid–containing peptide (DAACP). Here, we provide an example in native neuropeptides in which the DAACP and its all-L-amino acid epimer are both active at their newly identified receptor in vitro and at a neuronal target associated with feeding behavior. On the basis of sequence similarity to a known DAACP from cone snail venom, we hypothesized that allatotropin-related peptide (ATRP), a neuropeptide from the neuroscience model organism Aplysia californica, may form multiple diastereomers in the Aplysia central nervous system. We determined that ATRP exists as a D-amino acid–containing peptide (D2-ATRP) and identified a specific G protein–coupled receptor as an ATRP receptor. Interestingly, unlike many previously reported DAACPs and their all-L-residue analogs, both L-ATRP and D2-ATRP were potent agonists of this receptor and active in electrophysiological experiments. Finally, D2-ATRP was much more stable than its all-L-residue counterpart in Aplysia plasma, suggesting that in the case of ATRP, the primary role of the L- to D-residue isomerization may be to protect this peptide from aminopeptidase activity in the extracellular space. Our results indicate that L- to D-residue isomerization can occur even in an all-L-residue peptide with a known biological activity, and that in some cases, this PTM may help modulate peptide signal lifetime in the extracellular space rather than activity at the cognate receptor.